Aims and objectives of service. The Pharmacy First Minor Ailments Service is primarily designed as a “walk in” service so that patients exempt from prescription charges of all ages can access self-care advice for the treatment of minor ailments and, where appropriate, be supplied with over the counter medicines, without the requirement to attend their GP practice for an appointment and prescription.
Aims and objectives of service. 1. To improve the mental and emotional health and wellbeing of children with autism, through training and early intervention with parents and professionals.
2. To raise the expectations of parents, carers and professionals who will be working with children with autism and help them to realise the child’s full potential.
3. The programme will help families to: Understand their child’s autism Better cope with their autistic child’s behaviour Structure interactions to enable communication to develop Develop strategies to pre-empt challenging behaviours and deal with those that might occur Improve the quality of family life resulting in the prevention of family breakdown
Aims and objectives of service. To provide alternative options to facilitate stopping smoking; To reduce smoking related illnesses and deaths by supporting people to give up smoking; To improve the health of the North Lincolnshire population by reducing exposure to passive smoke; To facilitate behaviour change as a means to improving health and well-being.
Aims and objectives of service. The National Insulin Resistant Diabetes Service provides a multidisciplinary outpatient clinic at Cambridge University Hospitals NHS Foundation Trust (CUH) plus inpatient stays for initiation of therapy when indicated. The aim of the service is to provide diagnostic, therapeutic and educational support for both patients and their local clinical carers, and to establish and disseminate evidence-based recommendations for the therapy of this severe group of conditions. The service is targeted at patients with lipodystrophy and/or extreme insulin resistance as defined below (in 2.1). These are very rare but metabolically devastating disorders associated with significant long-term morbidity and mortality. The purpose of the service is to improve outcomes for these patients through the following mechanisms: • by providing a precise diagnosis wherever possible • by the provision of targeted specialist delivered treatment interventions including both dietary and pharmacological therapies • by educating patients, their relatives (where this is appropriate) and local health carers • by raising the profile of severe insulin resistance/lipodystrophy as a clinical problem in order to improve access to optimal care for affected patients. Objectives and expected outcomes Diagnosis Accurate clinical assessment is an essential step to putting the correct management strategies in place early for this group of patients. This requires close links to clinical biochemistry, molecular genetics and radiology services, to provide a complete, integrated package of clinical, biochemical and radiological evaluation as well as definitive molecular genetic diagnosis where appropriate. Objective 1 • To provide a specific diagnosis to all patients with lipodystrophy/severe insulin resistance. This is not currently possible as the genetic basis of several of the disease
Aims and objectives of service. To optimise patient vision and minimise avoidable visual disability, mortality and other morbidity by providing high quality care that meets the needs of adults with ophthalmic problems. • To provide the investigation and management of rare and/or complex visual, ocular and ocular adnexal disorders. • To ensure that there is a sufficient, skilled and competent multi-disciplinary workforce to manage adults with ophthalmic disorders. • To ensure that adults have their ophthalmic and general healthcare, education and social care plans coordinated. • To ensure patients are treated in line with national guidelines and agree local pathways. Treatment is predominately delivered in an outpatient setting and where appropriate as an inpatient (xxxx or day unit as required), with carefully monitored shared care arrangements in place with referring clinicians. There were 5.95 million attendances at English NHS Ophthalmology departments in 2009-10.1.69 million of these (28%) were first attendances. Specialised services are required to keep data to ensure coding is accurate. The service will deliver the aim to optimise vision and prevent avoidable visual disability of ophthalmic (eye and vision) disorders by: • making timely and accurate diagnoses • timely investigation and management • providing high quality proactive treatment and care • providing appropriate counselling and psychological support to patients • support patients with poor vision • support patients with long term conditions • support patients to manage their condition independently • ensuring effective communication between patients and service providers. • providing a personal service, sensitive to the physical, psychological and emotional needs of the patient. • provide advice, when appropriate, on Letter of Vision Impairment (LVI), Referral of Vision Impairment (RVI) and Certificate of Vision Impairment (CVI) Clinically this service covers all ophthalmic subspecialties and is therefore by definition heterogeneous
Aims and objectives of service. The key aims of the service is to: To improve the health outcomes for children and young people who have a neurodisability Early, appropriate and cost – effective Increase the focus on improving children‘s lives by ensuring that professional work together across organisational boundaries to meet the needs of the young people. The key objectives are to: To provide a high quality, timely consultant led medical service for children and young people with complex neurodisability for children and young people under the age of 19 (or during transition into adulthood). Through the provision of a multi-disciplinary neurodisability service, children young
Aims and objectives of service. In the United Kingdom (UK) up to 40 patients per year become dialysis dependent having under gone renal cancer surgery. Ex-vivo partial nephrectomy and renal auto- transplantation (EPN) is an operation that can be used to treat complex cancers in patients with a single kidney not suitable for other nephron sparing approaches. EPN offers suitable patients the possibility of cancer cure and avoidance of a life on dialysis. The overall aim of the service is to provide patients with complex renal tumours in solitary kidneys or bilateral disease not suitable for conventional treatments, the possibility of cancer cure and avoidance of dialysis. Between 1997 and 2007, approximately 300 patients in the UK developed end stage renal failure requiring renal replacement therapy as a direct consequence of renal cancer surgery (data from the UK renal register). A proportion of these patients may have avoided dialysis had they had the option of an EPN. We anticipate that 50% of the patients with complex T1-2 tumours may be suitable for an EPN. National commissioning of ex- vivo partial nephrectomy now means that up to 20 potentially salvageable patients will be no longer be rendered anephric and dialysis dependent. It is expected that the EPN service will result in significant quality of life and cost benefits to the health service in England.
Aims and objectives of service. 1.1 This service aims to improve health outcomes and quality of life amongst Hull residents by identifying individuals at an earlier stage of vascular change, and provide opportunities to empower them to substantially reduce their risk of cardiovascular morbidity or mortality.
Aims and objectives of service. The aim of the lung cancer service is to deliver high quality holistic care for patients with lung cancer so as to increase survival while maximising a patient’s functional capability and quality of life and to ensure ready and timely access to appropriate supportive care for patients, their relatives and carers. The service is delivered through primary care (prevention, recognition, referral and supportive and palliative care), and a local lung cancer multi-disciplinary team (MDT), with specialist providers (diagnosis, treatment, supportive and palliative care). Excellence in outcomes for lung cancer patients is dependent on factors crossing health sector boundaries. These include: A pro-active approach to prevention of lung cancer through smoking cessation. This is a priority for all smoking related diseases but in lung cancer the effect extends to better outcomes throughout the pathway. Primary, secondary and tertiary providers should include smoking cessation advice and referrals in their management of patients with suspected and diagnosed lung cancer. New tobacco control initiatives, as recommended by the Independent Cancer Taskforce should be supported. Awareness of the early symptoms of lung cancer and of the benefits of making the diagnosis early within the general population is vital A high level of awareness and prompt attention to warning symptoms in primary care Access to expert diagnostic and specialist treatment services.
Aims and objectives of service. The aim of the supranetwork penile cancer service is to deliver high-quality multidisciplinary holistic care aimed at increasing survival while maintaining sexual and urinary function, and quality of life. It also ensures ready and timely access to appropriate supportive care for patients, their relatives and carers. The service will be delivered through a supra-network penile multidisciplinary team, with some elements,(e.g.radiotherapy/chemotherapy) delivered at a local level depending upon the needs of the patient. All patients with penile cancer, both new and existing, should be managed by specialist multidisciplinary urological cancer teams. These teams should be established in large hospitals or cancer centres. All operations carried out by the penile cancer team should be carried out in a single hospital, which should also provide post-operative care and host the supranetwork multidisciplinary team (MDT) meetings. Documented clinical policies for referral and treatment should be agreed between cancer leads in primary care and lead clinicians representing urological, oncology and palliative care services throughout the network, and signed off by the lead clinician for the network. Effective systems will be required to ensure rapid communication and efficient co- ordination between teams. Patients with penile cancer should be managed by specialist penile cancer teams working at the supranetwork level. Such teams should serve up to four networks, with a combined population base of at least four million. These teams should liaise closely and regularly with local urological cancer teams, who themselves will be responsible for some aspects of the diagnosis and treatment of these cancers. The service is required to agree the following areas with their local cancer networks: • Service configuration and population coverage • Referral criteria, clinical protocols (including referral and management of post- operative patients, emergency protocols, and pathways that enable rapid access for treatment), network policies (including local surgical policies) and treatment pathways. • Engagement with the local network groups and National Cancer Peer Review for penile cancers under urological tumours. The overall objectives of the services are: • To provide care with a patient- and family-centred focus to deliver the best possible patient experience, contributing to and learning from patient experience and outcome measures. • To provide an exemplary and comprehensive s...
